Niacin/simvastatin
From Wikipedia, the free encyclopedia
Niacin/simvastatin
|
|
Combination of | |
Niacin | n/a |
Simvastatin | Statin |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Therapeutic considerations | |
Pregnancy cat. |
X(US) |
Legal status | |
Routes | Oral |
Niacin/simvastatin (brand name Simcor, Abbott) is a drug combination used for the treatment of dyslipidemia. It was approved by the FDA on February 15, 2008.[1]
[edit] References
|